Vaginal-perianal cultures for GBS in pregnancy preferred

Article

"Vaginal-perianal cultures for group B streptococcal infections (GBS) during pregnancy yield results comparable to vaginal-rectal cultures and cause less patient discomfort, a new study from Riverside Methodist Hospital and OhioHealth Research & Innovation Institute (Columbus, Ohio) reports. MORE "

Vaginal-perianal cultures for group B streptococcal infections (GBS) during pregnancy yield results comparable to vaginal-rectal cultures and cause less patient discomfort, a new study reports.

Researchers used swabs to collect vaginal-perianal samples followed by vaginal-rectal samples from 193 women 18 years and older at 35 to 37 weeks’ gestation. The overall agreement rate between the 2 culture methods was 96.4% (186 women) for a sensitivity of 91.1% and specificity of 98.5%. GBS detection rates were similar. Patients reported an average pain level of 1.2 points on a 0 to 10 scale for vaginal-perianal culture compared with 3.4 points for vaginal-rectal culture. The study was published in Obstetrics and Gynecology (2011;118[2, Part 1]:313-317).

The study “adds to the current body of evidence that suggests that vaginal-perianal cultures may be a reasonable, patient-preferred alternative for the collection of recommended cultures for detection of GBS during pregnancy,” the researchers write.

More than two-thirds of the patients said that the vaginal-perianal method caused less discomfort than vaginal-rectal culture. Slightly more than half of patients reported no pain with vaginal-perianal culture compared with 18.7% for vaginal-rectal culture.

Noting that their study didn’t assess neonatal health status, the researchers suggest that future research “could monitor early onset GBS disease in neonates after switching to vaginal-perianal collection methods.”

Read other articles in this issue of Special Delivery.

Recent Videos
HPV self-collection: Benefits, limitations, and future implications | Image Credit: forhers.com
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
New cervical cancer screening guidelines: What practitioners needs to know | Image Credit: forhers.com
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.